G1 Therapeutics Inc

G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engaged in developing novel, small-molecule therapies which address significant unmet needs in the treatment of cancer. The company's product pipeline consists of CDK4/6, Trilaciclib (G1T28), G1T38 and G1T48. G1 Therapeutics, Inc. is based in Research Triangle Park, NC.

Address Details

Address: 700 Park Offices Drive Suite 200

City: Research Triangle Park

State: NC

Country: USA

Zip Code: 27709